Welcome to kongre.net
Speaker
Chief Business Officer, Foghorn Therapeutics
Anna Rivkin, Chief Business Officer at Foghorn Therapeutics, spoke at Oncology & Immunology Innovation Partnering & Licensing Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Pharma Icebreaker Panel Discussion: Investing into Immune Rest, Rebalance & Reconstitution”.
9–10 Sept 2026Boston, United States of America
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Science Partner, Flagship Pioneering
Chief Business Officer, Nurix Therapeutics, Inc.
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
Chief Executive Officer, Synthis Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Anna Rivkin, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].